The ribbon was cut today at GSK’s recently expanded manufacturing facility in Rockville, marking the completion of a $139M project that was first announced in May 2017 to support growing demand for BENLYSTA® (belimumab), a treatment for adult patients with Lupus.
Image: https://biobuzz-io.cdn.ampproject.org
{iframe}https://biobuzz-io.cdn.ampproject.org/c/s/biobuzz.io/gsk-opens-139m-u-s-expansion-of-commercial-manufacturing-facility-in-rockville-maryland/amp/{/iframe}